In the NNK‐induced mouse lung carcinogenesis model, the correlation between increase in cell proliferation and activation of ERK1/2 suggests that ERK1/2 activation is involved in the process of malignant progression (adenoma to adenocarcinoma). Here, MAPK3 is linked to adenocarcinoma.